

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb243</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>The Cytotoxicity of Dacarbazine Potentiated by Sea Cucumber Saponin in Resistant B16F10 Melanoma Cells through Apoptosis Induction</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Baharara</surname><given-names>Javad</given-names></name></contrib><aff>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Amini</surname><given-names>Elaheh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Nikdel</surname><given-names>Najme</given-names></name></contrib><aff>Division of Pathology, Wayne State University, Detroit, MI,  United States of America</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Salek-Abdollahi</surname><given-names>Farzaneh</given-names></name></contrib><aff>Lumigen Instrument Center, Wayne State University, Detroit, MI, United States of America</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>8</volume>
      <issue>3</issue>
      <fpage>112</fpage>
      <lpage>119</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>2</month>
          <year>2016</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: Malignant melanoma is a highly aggressive malignant melanocytic neoplasm which resists against the most conventional therapies. Sea cucumber as one of marine organisms contains bioactive compounds such as polysaccharide, terpenoid and other metabolites which have anti-cancer, anti-tumor, anti-inflammatory and antioxidant properties. The present study was designed to investigate the anticancer potential of saponin extracted from sea cucumber &lt;em&gt;Holothuria leucospilata&lt;/em&gt; alone and in combination with dacarbazine on B16F10 melanoma cell line.&lt;br /&gt;
Methods: The B16F10 cell line was treated with different concentrations of saponin (0, 4, 8, 12, 16, 20 &lt;em&gt;&amp;micro;g/ml&lt;/em&gt;), dacarbazine (0, 1200, 1400, 1600, 1800, 2000&lt;em&gt; &amp;micro;g/ml&lt;/em&gt;) and co-administration of saponin-dacarbazine (1200 da+8 sp, 1200 da+4 sp) for 24 and 48 &lt;em&gt;hr&lt;/em&gt; and the cytotoxic effect was examined by MTT, DAPI, acridine orange/propodium iodide, flow cytometry and caspase colorimetric assay.&lt;br /&gt;
Results: The results exhibited that sea cucumber saponin, dacarbazine, and co-administration of saponin-dacarbazine inhibited the proliferation of melanoma cells in a dose and time dependent manner with IC&lt;sub&gt;50&lt;/sub&gt; values of 10, 1400 and 4+1200 &lt;em&gt;&amp;micro;g/ml&lt;/em&gt;, respectively. Morphological observation of DAPI and acridine orange/propodium iodide staining documented typical characteristics of apoptotic cell death. Flow cytometry assay indicated accumulation of IC&lt;sub&gt;50&lt;/sub&gt; treated cells in sub-G1 peak. Additionally, saponin extracted induced intrinsic apoptosis &lt;em&gt;via&lt;/em&gt; up-regulation of caspase-3 and caspase-9.&lt;br /&gt;
Conclusion: These results revealed that the saponin extracted from sea cucumber as a natural anti-cancer compound may be a new treatment modality for metastatic melanoma and the application of sea cucumber saponin in combination with dacarbazine demonstrated the strongest anti-cancer activity as compared with the drug alone.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
